vtheader-white

Program Objectives

  1. Provide a review of new information on the basic pathophysiology of ventricular arrhythmias.
  2. Provide an in-depth understanding of current management strategies used for the care of ventricular arrhythmias in various disease states, including non-pharmacological therapies such as implantable device and catheter ablation techniques.

At the conclusion of this symposium, participants should be able to:

  • Describe the science critical to the understanding and treatment of ventricular arrhythmias including:       
    • Biophysics of ablation
    • Anatomic substrate for ventricular tachycardia (VT)
  • Review the current status and future role for implantable cardioverter defibrillators (ICD) in the management of sudden cardiac death
  • Discuss the role of new techniques for VT substrate assessment including functional scar imaging, intra-procedure MRI, and high density mapping
  • Describe risk stratification and treatment including VT ablation in patients with arrhythmogenic right ventricular cardiomyopathy
  • Explain strategies to improve treatment outcome in patients with ventricular arrhythmias and structural heart disease including “bail out” strategies after failed catheter ablation
  • Review the current use/role of antiarrhythmic drug therapy for ventricular arrhythmias
  • Describe and manage complications of VT ablation
  • Identify techniques to improve ablation success for idiopathic arrhythmias including use of advanced imaging
  • Describe the status of ongoing multicenter VT-related trials and discuss which questions need to be answered by trials in the future

VT Symposium

VT Videos On Demand

cme

CME Certificate Fulfillment for 2018 Attendees

Click Here

shadow-div-content

Co-Hosted by:

logo Mount SinaiThe Mount Sinai Hospital

Penn Medicine logoHospital of the University
of Pennsylvania

Co-Sponsor:
HRS-Home logoshadow-div-content